Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 10/20 | 0.52 |
| ▸ | VCP | P55072 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1775730 | 0.86 | HRH4 (0.67) | HRH4VCPPIK3CBAPPSMN1; SMN2 | |
| SCHEMBL18636771 | 0.85 | HRH4 (0.60) | HRH4PIK3CBAPP | |
| SCHEMBL1774809 | 0.84 | HRH4 (0.54) | HRH4VCPPIK3CBAPPALDH1A1 | |
| SCHEMBL12605060 | 0.82 | HRH4 (0.74) | HRH4PIK3CBAPP | |
| SCHEMBL4392707 | 0.81 | HRH4 (0.64) | HRH4PIK3CB | |
| SCHEMBL12604976 | 0.79 | HRH4 (0.50) | HRH4VCPPIK3CBAPPALDH1A1 | |
| SCHEMBL1775871 | 0.77 | HRH4 (0.57) | HRH4VCPPIK3CB | |
| SCHEMBL1776133 | 0.77 | HRH4 (0.64) | HRH4 | |
| SCHEMBL1775312 | 0.76 | HRH4 (0.53) | HRH4APP | |
| SCHEMBL1774215 | 0.76 | HRH4 (0.53) | HRH4PIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1966162-B1 | PYRIMIDINE DERIVATIVES | ZIARCO PHARMA LTD (GB) | 2017-03-15 | — | — | EP | disclosed |
| US-7943628-B2 | Pyrimidine derivatives | PFIZER LIMITED (GB) | 2011-05-17 | — | — | US | disclosed |
| US-20070185075-A1 | Pyrimidine derivatives | PFIZER LIMITED | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185075-A1 | Pyrimidine derivatives | TYMS, DPYD, TYMP | HRH4 184/4885VCP 4285/4885L3MBTL1 1070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.